Adage Capital Partners Gp, L.L.C. Applied Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,211,629 shares of APLT stock, worth $486,558. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,211,629
Previous 1,211,629
82.53%
Holding current value
$486,558
Previous $375,000
253.6%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding APLT
# of Institutions
80Shares Held
97.7MCall Options Held
357KPut Options Held
301K-
T. Rowe Price Investment Management, Inc. Baltimore, MD21.4MShares$4.71 Million0.01% of portfolio
-
Vestal Point Capital, LP New York, NY14.3MShares$3.14 Million0.39% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$2.48 Million6.83% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$1.72 Million2.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$1.45 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $10.6M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...